Bret Heale, Ph.D.
Currently, I am working at the Medical Research Council – Human Genetics unit in Edinburgh, Scotland. My work is on the biological role of ADAR1 (adenosine deaminase acting on double-stranded RNA). The focus of the current work is to dissect the ADAR1 (adenosine deaminase acting on RNA1) protein and determine which parts are required to modulate RNA interference, how common this modulation is, and what cellular partners are essential for ADAR1 to affect RNA interference.
Pingfang Liu, Ph.D.
I am a postdoctoral fellow in the Bruce Demple lab at Harvard University. My research focuses on understanding the DNA repair mechanisms in mammalian mitochondria.
My son Patrick was born April 13.
Jing Song, Ph.D.
Jing was a postdoctoral fellow at Harvard University from 2006-2008.
I am writing to let you know that I have decided to go back to Beijing for a biotech position. The company I will work for is a medium size contract research company (CRO) called Bioduro, Inc. I will be a group leader/principal scientist there working on assay development and protein biochemistry support for a drug screening process.
Yuqing "Kate" Tu, Ph.D.
I would love to join my fellow classmates and mentors for the November Event, but it is unlikely that I can make it, as I took on a two-year assignment with Citibank (China). I have been living in Guangzhou, China, for the past 8 months.
This recent picture was taken in Taiwan on my last business trip.
Chunxia Tracy Li, Ph.D.
I am in my first year of medical residency at the UCSF/Fresno Family Medicine Program. It is a really tough program, but I am hanging in there.
Ziming Zhang, Ph.D.
Ziming is a project scientist at the Chemical Genomic Center at The Burnham Institute in La Jolla. His research focuses on developing NMR-based drug discovery techniques and applying these techniques to develop small molecular probes for protein, RNA and DNA targets with important biological functions.
Peizhang Xu, Ph.D.
Peizhang is a postdoctoral fellow in the Yuh-Nung Jan lab at the University of California, San Francisco. He is conducting a genetic and molecular study of microRNA and neural development.
Michael R. Lewis, Ph.D.
Graduated 1997Mike is an associate professor in the
Department of Veterinary Medicine & Surgery and the Department of Radiology at the University of Missouri Columbia.
Our research program focuses on the development, evaluation, and application of metal-based radiopharmaceuticals for diagnostic imaging and targeted radiotherapy of cancer in veterinary and human patients. One of our projects involves the development of a radiolabeled immunotoxin for targeted multi-modality therapy of breast, lung, and prostate cancer. A second project will evaluate radiolabeled pretargeting agents for multi-step radioimmunotherapy of colon and prostate cancer. The third project involves the design, synthesis, and evaluation of radiopharmaceuticals for diagnostic imaging of oncogene expression in lymphoma and lung, gastrointestinal, and pancreatic cancers.
Hsiao-Huei "Juli" Wu, Ph.D.
Juli Wu is assistant director of the Vanderbilt University Center for Stem Cell Biology in Nashville, Tennessee. Much of her time is spent developing the Beta Cell Biology Consortium research core. She is also a research instructor in the Department of Biochemistry.
Lingwen Zhong, Ph.D.
Here's my picture with the background of Niagara Falls. Isn't it spectacular! Roswell Park Cancer Institute, where I'm working, is just about 20 miles away from this great falls.
As for my work, my research projects focus on investigating the molecular mechanisms underlying the thermal regulation of T cell activation and differentiation. I am also interested in developing novel immunotherapeutic protocols to use mild hyperthermia treatment as an adjuvant of cancer vaccine to control the growth of breast tumors.
Shuo Gu, Ph.D., and Lan Jin, Ph.D.
Graduated 2005 and 2007
Lan and Shuo are postdocs in the Mark Kay lab at Stanford University. They are working on the same project, which is focused on understanding the mechanism of microRNA-mediated translational repression.
They will be visiting family in China during the reunion. “We are so sorry to miss this spectacular chance to meet all the old friends. Please say hi for us to everyone attending the reunion.”